Mariner
NAGE

Mariner’s Niagen Bioscience NAGE Stock Holding History

Mariner’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$216K Buy
48,998
+30,406
+164% +$164K ﹤0.01% 3126
2025
Q4 		$118K Sell
18,592
-658
-3% -$4.58K ﹤0.01% 3299
2025
Q3 		$180K Buy
19,250
+250
+1% +$2.52K ﹤0.01% 3211
2025
Q2 		$274K Buy
+19,000
New +$188K ﹤0.01% 2792

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mariner's NAGE Position: Q1 2026 in Review

Mariner increased its Niagen Bioscience (NAGE) stake by 164% in Q1 2026, buying an estimated $164K and bringing the position to 48,998 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #3126.

Mariner first reported a position in NAGE in Q2 2025 and has held it in 4 quarters since. The position peaked at $274K in Q2 2025. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • Mariner held 48,998 shares of Niagen Bioscience worth $216K as of Q1 2026.
  • Mariner bought 30,406 Niagen Bioscience shares in Q1 2026, an estimated $164K.
  • Niagen Bioscience made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #3126 holding.
  • Mariner first reported a position in Niagen Bioscience in Q2 2025 and has held it in 4 quarters since.
  • Mariner's Niagen Bioscience position peaked at $274K in Q2 2025.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.